NCT05380336View on ClinicalTrials.gov

Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer

CompletedOBSERVATIONAL
Enrollment

40,000

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Metastatic Cancer
All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT05380336 - Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer | Biotech Hunter | Biotech Hunter